Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program for Ruxolitinib Cream in Atopic Dermatitis
WILMINGTON, Del.--(BUSINESS WIRE)--Dec. 20, 2018-- Incyte (Nasdaq:INCY) today announced that the first patient has been...
Health News 2 me
healthnews2me.com
Tag: Atopic